Ranbaxy
Ranbaxy to appeal US District Court decision upholding Pfizer Atorvastatin Patents
By Atorvastatin is a chol | 19 Dec 2005
Ranbaxy offers to help U S combat avian flu
By | 02 Dec 2005
Ranbaxy honours scientists for outstanding research
By The foundation has bee | 28 Nov 2005
US Court of Appeals upholds preliminary injunction against Ranbaxy
By Ranbaxy had appealed t | 23 Nov 2005
AstraZeneca sues Ranbaxy on Nexium patent
By Our Corporate Bureau | 22 Nov 2005
CRISIL reaffirms Ranbaxy''s outstanding ratings despite court ruling
By | 15 Oct 2005
Ranbaxy obtains US FDA approval for high BP drug
By Our Corporate Bureau | 14 Sep 2005
Ranbaxy, JB Chem to market Doktor Mom brand in Romania
By Our Corporate Bureau | 06 Jul 2005
Ranbaxy makes three fresh ARV filings to WHO
By This comes shortly after | 25 Jan 2005
Ranbaxy Top brass reshuffled
By | 22 Jan 2005
Ranbaxy Q4 results disappoints
By Profit before tax stood | 19 Jan 2005
Ranbaxy withdraws its antiretroviral''s from WHO list
By Ranbaxy decided on the w | 10 Nov 2004
Fortis to invest over Rs1,100 crore in integrated healthcare delivery system
By Our Corporate Bureau | 17 Aug 2004
Ranbaxy net down six per cent
By Total income during the | 02 Aug 2004
Ranbaxy in pact for new drug discovery
By Ranbaxy and NIPER had jo | 30 Apr 2004
Ranbaxy crosses the billion dollar mark
By New Delhi: | 11 Mar 2004
Ranbaxy enters the field of herbal medicine
By New Delhi: | 22 Jan 2004
USFDA approval for Ranbaxy drug
By New Delhi: | 10 Jan 2004
WHO declares pre-qualification of Ranbaxy''s Triviro-LNS tablets
By Mumbai: | 04 Dec 2003
Ranbaxy to invest Rs 120 crore for R&D in Andhra Pradesh
By Hyderabad: | 22 Sep 2003
Ranbaxy to provide AIDS drugs to 10 lakh patients
By New Delhi: | 29 Nov 2002
Ranbaxy Laboratories clocks Rs 1,594-million Q2 net profit
By Mumbai: | 18 Oct 2002
Ranbaxy gets USFDA approval for Terazosin
By Pradeep Rane | 26 Sep 2002
Ranbaxy secures 10% stake in Nihon Pharma
By Pradeep Rane | 26 Sep 2002
Featured articles
Lighter than air, yet very, very powerful
By Kiron Kasbekar | 03 Jan 2024
In March 2013 Chinese scientists pulled off a remarkable feat. They created the world’s lightest aerogel. Tipping the scales at a mere 0.16 milligrams per cubic centimeter – that’s a sixth of the weight of air!
COP28 explained: A closer look at COP28's climate change solutions
By Aniket Gupta | 27 Dec 2023
The 28th United Nations Climate Change Conference, also known as COP28, took place from 30th November 2023, to 13th December 2023, at Expo City in Dubai, United Arab Emirates.
What is a Ponzi scheme?
By Aniket Gupta | 06 Dec 2023
Ponzi schemes have long captivated the public imagination, drawing unsuspecting investors into a web of illusion and deception.
The Rise and Rise of HDFC Bank
03 Jul 2023
HDFC, which surged ahead of global majors like HSBC Holdings Plc and Citigroup Inc and left Indian peers like State Bank of India and ICICI Bank in market capitalisation, now ranks fourth largest among the world’s most valuable banks, after JPMorgan Chase & Co, Industrial and Commercial Bank of China Ltd and Bank of America Corp
India’s Millet Revolution To Enrich Global Food Basket
02 Apr 2023
Millets, a healthier and cheaper substitute to wheat and rice, are indigenous to many parts of the world, especially in the semiarid tropics of Asia and Africa, and offers a big scope for expanding production and consumption in the foodgrain deficient African continent
Market predator Hindenburg preys on Adani stock
06 Mar 2023
Almost a month after the damning report of short-seller Hindenburg Research on the Adani Group that claimed that the seven stocks within the group were about 85 per cent overvalued, one of the group's stocks, Adani Total Gas, closed at Rs835 on the BSE, down nearly 79 per cent from its 24 January level, almost close to reaching that valuation
.jpg "Microsoft, Google challenge Delhi HC order to remove non-consensual content")
